Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
FPH02 - A Phase III, Randomized, Double-blind, Placebo-controlled Safety and Efficacy Study of Sitaxsentan Sodium Treatment with an Open-Label Bosentan Arm in Patients with Pulmonary Arterial Hypertension (STRIDE II).
Booth, David
(PI)
Buch, Ketan
(CoI)
Schroeder, Valerie
(CoI)
Internal Medicine
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
2/2/04
→
12/31/06
Funding
ENCYSIVE LP admin by ResearchPoint:
$12,450.00
View all
View less